Nov 06, 2023, 19:00 ET The ultra-small 1cm patch, which only needs to be applied once a week, dramatically increases user convenience Daewoong Therapeutics employs the 'CLOPAM' platform to develop 'advanced formulations,' with plans for commercialization by 2028 CEO Seung-Ho Jeon states, "By developing the GLP-1 analogue patch-type formulation, we aim to meet the unmet needs of patients and medical professionals." SEOUL, South Korea, Nov
Achieving the best results requires a comprehensive approach that includes medication, dietary changes, and physical activity
Non psammomatous melanocytic schwannoma presenting as a subcutaneous nodule: A rare presentation of a rare lesion
What began as a discovery in the saliva of a desert reptile has now led to therapies that help millions of people manage blood sugar levels and body weight
How Long Does It Take to See Results